Skip to main content

Table 1 Main baseline features of the 13 patients meeting ASAS criteria [30] for axial spondyloarthritis

From: Is IL-6 an appropriate target to treat spondyloarthritis patients refractory to anti-TNF therapy? a multicentre retrospective observational study

 

Patient 1

Patient 2

Patient 3

Patient 4

Patient 5

Patient 6

Patient 7

Type of SpA

AS

AS

AS

AS

AS

AS

AS

Sacroiliitis

Grade 4

Grade 4

Grade 3

Grade 4

Grade 3

Grade 3

Grade 4

HLA-B27

+

+

+

+

+

+

+

Gender

Female

Female

Female

Male

Male

Female

Male

Disease duration (years)

9

27

11

6

4

24

19

Main location of inflammatory pain

Back, neck, chest, peripheral enthesitis (Achilles tendon, knee)

Neck, chest, peripheral enthesitisa

Back, buttock, chest

Neck

Back, neck, buttock

Back, neck, chest

Back, neck, peripheral enthesitis (Achilles tendon)

Concomitant NSAIDs/steroids (dosage)

Yes/no

Yes/no

Yes/no

No/no

No/no

Yes/no

Yes/no

Concomitant DMARDs

No

No

No

Sulfasalazine

No

No

No

Previous biologics other than anti-TNF

Abatacept

Abatacept

Abatacept

No

No

No

No

 

Patient 8

Patient 9

Patient 10

Patient 11

Patient 12

Patient 13

 

Type of SpA

AS and PsA

uSpA

uSpA

uSpA

uSpA

uSpA

 

Sacroiliitis

Grade 3

Grade 1

Grade 0

Grade 0

Grade 0

Grade 0

 

HLA-B27

-

+

+

+

+

+

 

Gender

Male

Female

Female

Male

Female

Male

 

Disease duration (years)

15

11

9

25

6

12

 

Main location of inflammatory pain

Back, neck, arthritis

Back, neck, buttock, chest

Back, buttock

Back, neck, buttock

Back, buttock, chest, peripheral enthesitis (Achilles tendon)

Back, neck

 

Concomitant NSAIDs/steroids (dosage)

No/no

Yes/no

Yes/no

No/no

Yes/no

No/yes (25 mg/day)

 

Concomitant DMARDs

No

No

No

No

No

No

 

Previous biologics other than anti-TNF

Rituximab

Abatacept

Abatacept

No

No

No

 
  1. AS, ankylosing spondylitis meeting modified New York criteria [33]; ASAS, Assessment of SpondyloArthritis International Society; DMARD, disease-modifying antirheumatic drug; NSAID, nonsteroidal anti-inflammatory drug; PsA, psoriatic arthritis meeting Classification Criteria for Psoriatic Arthritis [36]; SpA, spondyloarthritis; uSpA, undifferentiated spondyloarthritis. aLocation unknown.